FischerMSchwabeCSchulteKL. Value of the Hemobahn/Viabahn Endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther.2006; 13: 281–290.
2.
BrayPJRobsonWJBrayAE. Percutaneous treatment of long superficial femoral artery occlusive disease: Efficacy of the Hemobahn stent-graft. J Endovasc Ther.2003; 10: 619–628.
3.
LammerJDakeMDBleynJ. Peripheral arterial obstruction: Prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000; 217: 95–104.
4.
VirmaniRKolodgieFDDakeMD. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol.1999; 10: 445–456.
5.
LammerJ. Femoropopliteal artery obstructions: From the balloon to the stent-graft. Cardiovasc Intervent Radiol.2001; 24: 73–83.
6.
MarinJVeithFCynamonJ. Human transluminally placed endovascular stented grafts: Preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg.1995; 21: 595–604.
7.
MarinJVeithFCynamonJ. Effect of PTFE covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries. J Vasc Interv Radiol.1996; 7: 651–656.
8.
AriyoshiHOkuyamaMOkaharaK. Expanded polytetrafluoroethylene (ePTFE) vascular graft loses its thrombogenicity six months after implantation. Thromb Res.1997; 5: 427–433.
9.
MohamedMSMukherjeeMKakkarVV. Thrombogenicity of heparin and non-heparin bound arterial prostheses: An in vitro evaluation. J R Coll Surg Edinb.. 1998; 43: 155–157.
10.
RashidSNClarkHGVannRD. The effect of interstitial air on the in vitro thrombogenicity of ePTFE vascular grafts. J Bioact Compat Polym.1992; 7: 54–64.
11.
SchillingerMSabetiSLoeweC. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med.2006; 354: 1879–1888.
